CRF Induces Intestinal Epithelial Barrier Injury via the Release of Mast Cell Proteases and TNF-α
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index; 2 of the 26 sources its claims cite were checked for support.
Abstract
BACKGROUND AND AIMS: Psychological stress is a predisposing factor in the onset and exacerbation of important gastrointestinal diseases including irritable bowel syndrome (IBS) and the inflammatory bowel diseases (IBD). The pathophysiology of stress-induced intestinal disturbances is known to be mediated by corticotropin releasing factor (CRF) but the precise signaling pathways remain poorly understood. Utilizing a porcine ex vivo intestinal model, the aim of this study was to investigate the mechanisms by which CRF mediates intestinal epithelial barrier disturbances. METHODOLOGY: Ileum was harvested from 6-8 week-old pigs, mounted on Ussing Chambers, and exposed to CRF in the presence or absence of various pharmacologic inhibitors of CRF-mediated signaling pathways. Mucosal-to-serosal flux of 4 kDa-FITC dextran (FD4) and transepithelial electrical resistance (TER) were recorded as indices of intestinal epithelial barrier function. RESULTS: Exposure of porcine ileum to 0.05-0.5 µM CRF increased (p<0.05) paracellular flux compared with vehicle controls. CRF treatment had no deleterious effects on ileal TER. The effects of CRF on FD4 flux were inhibited with pre-treatment of tissue with the non-selective CRF(1/2) receptor antagonist Astressin B and the mast cell stabilizer sodium cromolyn (10(-4) M). Furthermore, anti-TNF-α neutralizing antibody (p<0.01), protease inhibitors (p<0.01) and the neural blocker tetrodotoxin (TTX) inhibited CRF-mediated intestinal barrier dysfunction. CONCLUSION: These data demonstrate that CRF triggers increases in intestinal paracellular permeability via mast cell dependent release of TNF-α and proteases. Furthermore, CRF-mast cell signaling pathways and increases in intestinal permeability require critical input from the enteric nervous system. Therefore, blocking the deleterious effects of CRF may address the enteric signaling of mast cell degranulation, TNFα release, and protease secretion, hallmarks of IBS and IBD.
Overview
CoChat Summary
TL;DR
Using an ex vivo porcine ileum Ussing chamber model, the paper shows that CRF increases paracellular permeability without changing TER. The barrier effect depends on mast cell degranulation, TNF-α and protease activity, and requires enteric neural signaling.
Key findings
- CRF at 0.05, 0.1, and 0.5 µM increased FD4 flux across porcine ileal mucosa compared with vehicle controls (p<0.05), but did not affect TER over 180 min.
- Astressin B (1 µM) prevented CRF-induced increases in FD4 flux, indicating CRF receptor-mediated effects.
- 0.5 µM CRF induced mast cell degranulation and increased release of mast cell tryptase and TNF-α; sodium cromolyn (10−4 M) blocked mast cell degranulation, FD4 flux increases, and TNF-α elevation.
- Protease inhibitors and anti-TNF-α each inhibited CRF-stimulated FD4 flux (p<0.01), and TTX blocked both baseline and CRF-mediated mast cell degranulation and FD4 flux.
Methods
- Ex vivo study using ileum from 6–8 week-old pigs mounted in Ussing chambers; tissues were exposed to CRF with or without pharmacologic inhibitors.
- Barrier function was assessed by mucosal-to-serosal FD4 flux and transepithelial electrical resistance (TER); additional readouts included histology, mast cell degranulation counts, TNF-α ELISA, tryptase assay, and occludin immunofluorescence.
- Statistical analysis used one-way ANOVA with Fisher’s LSD post hoc test; mast cell counts used the Mann-Whitney test.
Limitations
- The paper states that the pharmacologic approach could not distinguish whether CRF effects were mediated by direct mast cell receptor activation or indirectly via enteric neurons, because CRF receptors are expressed on both.
- The authors note they could not discern which specific mast cell proteases were responsible because the protease inhibitor cocktail contained inhibitors of both tryptase and chymase.
- Evident from the text: the work is an ex vivo porcine ileum model, so the findings are not direct in vivo or human clinical evidence.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
0 Valid · 0 Not valid · 14 Not checked · 28 Own results and interpretations
None of the sources cited for this claim have been checked yet.
In the paper
“a critical event in the onset of clinical symptoms of GI disorders including irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD) [7], [8], [9], [10]”
§ CRF Induces Intestinal Epithelial Barrier Injury via the Release of Mast Cell Proteases and TNF-α > Introduction
What the sources say
- Could not verifycites [7] Aggarwal A Cutts TF Abell TL Cardoso S Familoni B 1994 Predominant symptoms in irritable bowel syndrome correlate with specific autonomic nervous system abnormalities. Gastroenterology 106 945 950 8143999 sourceExperimental — accuracy not yet measured
Our full-text copy of Aggarwal et al. (1994) is entirely about autonomic function (vagal cholinergic RR1, sympathetic adrenergic PAR/VC), radiopaque-marker colon transit and MMPI/MBHI/SIP psychological profiles in 21 IBS patients; no passage mentions intestinal permeability, gut barrier, or inflammatory bowel disease (searched: 'intestinal permeability critical event onset clinical symptoms', 'permeability lactulose mannitol gut barrier tight junction inflammation', 'pathophysiology hypothesis'). The Introduction (p. 1) frames pathophysiology only in terms of motor disorder, psychological factors and autonomic imbalance ('the overall pathophysiology of the disorder is not well understood'), so it neither supports nor contradicts a permeability claim. Absence of the point is not grounds for disputed, and the paper credits no other work for a permeability finding, so misattribution cannot be established either. (LLM, conf=0.75)
- Could not verifycites [8] Bennett EJ Tennant CC Piesse C Badcock CA Kellow JE 1998 Level of chronic life stress predicts clinical outcome in irritable bowel syndrome. Gut 43 256 261 10189854 PMC1727204 sourceExperimental — accuracy not yet measured
Our copy of Bennett et al. (1998, Gut) is entirely a prospective study of chronic life stress threat and subsequent symptom intensity/clinical outcome in 117 IBS/FD outpatients (Abstract; Discussion; Table 3); nothing in it addresses intestinal permeability, barrier function, or inflammatory bowel disease. Searches for 'intestinal permeability' and 'gut barrier permeability / mucosal inflammation' returned only stress-outcome passages and reference lists, and the paper's patients were required to have 'absence of organic disease by appropriate investigations' (PATIENTS section), so IBD/permeability mechanisms are outside its scope. The claim attributed to this citation is therefore not checkable against our copy. (LLM, conf=0.70)
- Not checked yetcites [9] Delvaux MM 1999 Stress and visceral perception. Can J Gastroenterol 13 Suppl A 32A 36A 10202206
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Pre-treatment of porcine ileal tissues with the mast cell stabilizing agent, sodium cromolyn (10−4 M), blocked CRF-mediated mast cell degranulation (Figures 5, 6C) and increases in FD4 flux (Figure 6D).”
§ CRF Induces Intestinal Epithelial Barrier Injury via the Release of Mast Cell Proteases and TNF-α > Results > Mast Cell Degranulation is required for CRF-mediated Increases in Paracellular Permeability in the Porcine Ileum
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Under baseline condition (no CRF), PI and the higher anti-TNF-α (10 µg/mL) reduced baseline FD4 flux indicating the influence of proteases and TNF-α under basal conditions.”
§ CRF Induces Intestinal Epithelial Barrier Injury via the Release of Mast Cell Proteases and TNF-α > Results > Blockade of TNF-α and Protease Activity Prevents CRF-induced Gut Barrier Dysfunction
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“protease inhibitors (p<0.01) and the neural blocker tetrodotoxin (TTX) inhibited CRF-mediated intestinal barrier dysfunction.”
- Also stated in: § Blockade of TNF-α and Protease Activity Prevents CRF-induced Gut Barrier Dysfunction · plain
“Protease inhibitors (PI) and anti-TNF-α (0.1 and 10 µg/mL) inhibited CRF-stimulated elevations in FD4 flux (Figure 7A–B).”
§ CRF Induces Intestinal Epithelial Barrier Injury via the Release of Mast Cell Proteases and TNF-α > Abstract > Results
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Blockade of TNF-α and Protease Activity Prevents CRF-induced Gut Barrier Dysfunction · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Histological analysis revealed no disruption of intestinal epithelial continuity with CRF (0.5 µM) treatment (Figure 3) indicating that the effects of CRF were due to alterations in the paracellular flux pathways rather than destruction of the epithelium.”
§ CRF Induces Intestinal Epithelial Barrier Injury via the Release of Mast Cell Proteases and TNF-α > Results > Influence of CRF on Porcine Ileal Intestinal Barrier Function
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
21 more claims
Create a free account to see all 42 claims and to verify the 24 references still open.
- It may state two separate claims as one. 10
- Probably not a substantial claim. 7
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Blocking CRF restrains the development of IBD by inhibiting mast cell degranulation and reducing tumor necrosis factor-alpha (TNF-α) and protease production (27).”
From Stress triggers flare of inflammatory bowel disease in children and adults (2019) · cites this paper as [27]
In the citing paper
“Furthermore, increases in sensory receptor expression, nerve hyperplasia, systemic inflammatory reactions, and stress may also contribute to IC/BPS [33].”
From The Pathomechanism and Current Treatments for Chronic Interstitial Cystitis and Bladder Pain Syndrome (2024) · cites this paper as [33]
Citations
Cites
The Hypothalamic–Pituitary–Adrenal Axis and Immune-Mediated Inflammation
Chrousos, G. P. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505183322008 · Cited by 2,579
Ma, T. Y., Iwamoto, G. K., Hoa, N. T., Akotia, V., Pedram, A., Boivin, M. A., & Said, H. M. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00173.2003 · Cited by 909
Tight Junction Pore and Leak Pathways: A Dynamic Duo
Shen, L., Weber, C. R., Raleigh, D. R., Yu, D., & Turner, J. R. (2011) · Annual Review of Physiology · doi:10.1146/annurev-physiol-012110-142150 · Cited by 872 · cited 1×
“These ‘leak’ and ‘pore’ pathways, respectively, are quickly gaining evidence for differential regulation of paracellular permeability pathways [29,34], and Figure 5.”
Mast cell-orchestrated immunity to pathogens
Abraham, S. N., & St. John, A. L. (2010) · Nature Reviews Immunology · doi:10.1038/nri2782 · Cited by 837 · cited 1×
“inflammatory mediators, including de novo synthesized mediators such as prostaglandins, leukotrienes, and cytokines or preformed granule-housed mediators including histamine, serine proteases, tryptase, chymase, and cytokines [18], which profoundly influence intestinal epithelial barrier function; however, the mast ce…”
Restoration of Barrier Function in Injured Intestinal Mucosa
Blikslager, A. T., Moeser, A. J., Gookin, J. L., Jones, S. L., & Odle, J. (2007) · Physiological Reviews · doi:10.1152/physrev.00012.2006 · Cited by 574 · cited 1×
“The gastrointestinal barrier, consisting primarily of intestinal epithelial cells, mucus layer, and sub-epithelial immune cells, selectively controls the access of the immense luminal load of antigens and resident microorganism to the underlying lamina propria immune tissues [1].”
Self-citationEarly weaning stress impairs development of mucosal barrier function in the porcine intestine
Smith, F., Clark, J. E., Overman, B. L., Tozel, C. C., Huang, J. H., Rivier, J. E. F., Blisklager, A. T., & Moeser, A. J. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00081.2009 · Cited by 500 · cited 3×
“13 cm(2) aperture Ussing chambers, as described in previous study [5,49].”
Self-citationMarchiando, A. M., Shen, L., Graham, W. V., Weber, C. R., Schwarz, B. T., Austin, J. R., Raleigh, D. R., Guan, Y., Watson, A. J. M., Montrose, M. H., et al. (2010) · Journal of Cell Biology · doi:10.1083/jcb.200902153 · Cited by 477 · cited 2×
“For example, TNF-a has been shown to initiate MLCK dependent changes in size selectivity of the tight junction to enhance paracellular flux of uncharged macromolecules without affecting charge, while IL-13 dependent claudin-2 expression was shown to increase paracellular permeability to cation flux in vitro and in viv…”
Neuropeptides activate human mast cell degranulation and chemokine production
Kulka, M., Sheen, C. H., Tancowny, B. P., Grammer, L. C., & Schleimer, R. P. (2008) · Immunology · doi:10.1111/j.1365-2567.2007.02705.x · Cited by 445
Level of chronic life stress predicts clinical outcome in irritable bowel syndrome
Bennett, E. J., Tennant, C. C., Piesse, C., Badcock, C.-A., & Kellow, J. E. (1998) · Gut · doi:10.1136/gut.43.2.256 · Cited by 405
Mast Cell Tryptase Controls Paracellular Permeability of the Intestine
Jacob, C., Yang, P.-C., Darmoul, D., Amadesi, S., Saito, T., Cottrell, G. S., Coelho, A.-M., Singh, P., Grady, E. F., Perdue, M., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506338200 · Cited by 334
Research works printed but not linked: 1
- Johnson DA 2006 Human Mast Cell Proteases. In: Mast Cells: Methods and Protocols. Totowa, New Jersey: Humana Press pp193–202.
Cited by
The vagus nerve at the interface of the microbiota-gut-brain axis
Bonaz, B., Bazin, T., & Pellissier, S. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00049 · Cited by 1,397
“CRF also increases intestinal permeability via mast cell release of tumor necrosis factor (TNF)-α and proteases (Overman et al., 2012).”
BackgroundKelly, J. R., Kennedy, P. J., Cryan, J. F., Dinan, T. G., Clarke, G., & Hyland, N. P. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00392 · Cited by 1,110
“Corticotrophin releasing factor (CRF) and its receptors (CRFR1 and CRFR2), play a key role in stress-induced gut permeability dysfunction (Overman et al., 2012; RodiñoJaneiro et al., 2015; Taché and Million, 2015).”
BackgroundBrain–Gut Interactions in Inflammatory Bowel Disease
Bonaz, B. L., & Bernstein, C. N. (2013) · Gastroenterology · doi:10.1053/j.gastro.2012.10.003 · Cited by 667
“Stress and CRF increase colonic permeability in rats (49) following activation of mast cells through a CRF receptor-dependent mechanism (50) via mast cell dependent release of TNF-a and proteases (51).”
BackgroundPetra, A. I., Panagiotidou, S., Hatziagelaki, E., Stewart, J. M., Conti, P., & Theoharides, T. C. (2015) · Clinical Therapeutics · doi:10.1016/j.clinthera.2015.04.002 · Cited by 592
The role of inflammation and the gut microbiome in depression and anxiety
Peirce, J. M., & Alviña, K. (2019) · Journal of Neuroscience Research · doi:10.1002/jnr.24476 · Cited by 466
Moeser, A. J., Pohl, C. S., & Rajput, M. (2017) · Animal nutrition · doi:10.1016/j.aninu.2017.06.003 · Cited by 452
“In vivo and ex vivo studies demonstrated an interplay between the CRF receptor activation andmast cells as CRF applied to porcine intestinewas shown to increase intestinal permeability via a mechanism involving release of mast cell proteases and TNFa (Overman et al., 2012; Smith et al., 2010).”
BackgroundSelf-citationHu, C. H., Xiao, K., Luan, Z. S., & Song, J. (2013) · Journal of Animal Science · doi:10.2527/jas.2012-5796 · Cited by 402
“The fl ux of intact FD4 across the intestinal epithelium occurs mainly through paracellular pathways (Hamard et al., 2010; Overman et al., 2012).”
BackgroundSharkey, K. A., & Mawe, G. M. (2023) · Physiological Reviews · doi:10.1152/physrev.00018.2022 · Cited by 390
The role of neuroimmune signaling in alcoholism
Crews, F. T., Lawrimore, C. J., Walter, T. J., & Coleman, L. G. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.01.031 · Cited by 321
“…as noradrenaline causes Hsp72 release from neutrophils (Giraldo et al., 2010) or endotoxin release due to increased intestinal permeability (AitBelgnaoui et al., 2012; Ferrier et al., 2003) that may involve CRF release (Overman et al., 2012; Saunders et al., 2002; Teitelbaum et al., 2008).”
Critical review evaluating the pig as a model for human nutritional physiology
Roura, E., Koopmans, S.-J., Lallès, J.-P., Le Huerou-Luron, I., de Jager, N., Schuurman, T., & Val-Laillet, D. (2016) · Nutrition Research Reviews · doi:10.1017/s0954422416000020 · Cited by 303
Porcine models of digestive disease: the future of large animal translational research
Gonzalez, L. M., Moeser, A. J., & Blikslager, A. T. (2015) · Translational Research · doi:10.1016/j.trsl.2015.01.004 · Cited by 276
Self-citationHorst, E. A., Kvidera, S. K., & Baumgard, L. H. (2021) · Journal of Dairy Science · doi:10.3168/jds.2021-20330 · Cited by 263
The Spectrum of Achalasia: Lessons From Studies of Pathophysiology and High-Resolution Manometry
Kahrilas, P. J., & Boeckxstaens, G. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.08.038 · Cited by 235
Potential Mechanisms Underlying Centralized Pain and Emerging Therapeutic Interventions
Eller-Smith, O. C., Nicol, A. L., & Christianson, J. A. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00035 · Cited by 227
“CRF signaling influences both contractility (Buckley et al., 2014) and transepithelial resistance (Overman et al., 2012) of the gastrointestinal tract.”
BackgroundRole of gut microbiota in cardiovascular diseases
Novakovic, M., Rout, A., Kingsley, T., Kirchoff, R., Singh, A., Verma, V., Kant, R., & Chaudhary, R. (2020) · World Journal of Cardiology · doi:10.4330/wjc.v12.i4.110 · Cited by 202
Large Animal Models: The Key to Translational Discovery in Digestive Disease Research
Ziegler, A., Gonzalez, L., & Blikslager, A. (2016) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2016.09.003 · Cited by 202
Crosstalk at the mucosal border: importance of the gut microenvironment in IBS
Öhman, L., Törnblom, H., & Simrén, M. (2015) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2014.200 · Cited by 181
Leigh, S., Uhlig, F., Wilmes, L., Sanchez‐Diaz, P., Gheorghe, C. E., Goodson, M. S., Kelley‐Loughnane, N., Hyland, N. P., Cryan, J. F., & Clarke, G. (2023) · The Journal of Physiology · doi:10.1113/jp281951 · Cited by 167
Stress triggers flare of inflammatory bowel disease in children and adults
Sun, Y., Li, L., Xie, R., Wang, B., Jiang, K., & Cao, H. (2019) · Frontiers in Pediatrics · doi:10.3389/fped.2019.00432 · Cited by 171
“Blocking CRF restrains the development of IBD by inhibiting mast cell degranulation and reducing tumor necrosis factor-alpha (TNF-α) and protease production (27).”
BackgroundWang, H., Zhang, C., Wu, G., Sun, Y., Wang, B., He, B., Dai, Z., & Wu, Z. (2015) · The Journal of Nutrition · doi:10.3945/jn.114.202515 · Cited by 168
The gut microbiome and mental health: implications for anxiety- and trauma-related disorders
Malan-Muller, S., Valles-Colomer, M., Raes, J., Lowry, C. A., Seedat, S., & Hemmings, S. M. J. (2018) · OMICS: A Journal of Integrative Biology · doi:10.1089/omi.2017.0077 · Cited by 161
“…to increase intestinal permeability, probably through the involvement of corticotrophin releasing factor (CRF) and its receptors (CRFR1 and CRFR2), which play a key role in stress-induced gut permeability dysfunction (Overman et al., 2012; Rodin˜o-Janeiro et al., 2015; Tache´ and Million, 2015).”
Brain and gut CRF signaling: biological actions and role in the gastrointestinal tract
Tache, Y., Larauche, M., Yuan, P.-Q., & Million, M. (2018) · Current Molecular Pharmacology · doi:10.2174/1874467210666170224095741 · Cited by 147
“The content of mast cells can in turn lead to the release of several preformed (histamine, 5-HT, protease) or newly synthesized compounds (PGE2, cytokines, nerve growth factor, tumor necrosis factor-α) [261] known to influence permeability and also to activate or sensitize sensory afferents [262, 263].”
BackgroundMast Cells and Irritable Bowel Syndrome: From the Bench to the Bedside
Zhang, L., Song, J., & Hou, X. (2016) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm15137 · Cited by 138
“which could be reproduced by peripheral administration of CRF, and blocked by CRF1/2 receptor antagonist, mast cell stabilizers, and protease inhibitors.(86)”
BackgroundJiang, Y., Song, J., Xu, Y., Liu, C., Qian, W., Bai, T., & Hou, X. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119254 · Cited by 132
Cytokines and intestinal epithelial permeability: A systematic review
Meyer, F., Wendling, D., Demougeot, C., Prati, C., & Verhoeven, F. (2023) · Autoimmunity Reviews · doi:10.1016/j.autrev.2023.103331 · Cited by 145
Pohl, C. S., Medland, J. E., Mackey, E., Edwards, L. L., Bagley, K. D., DeWilde, M. P., Williams, K. J., & Moeser, A. J. (2017) · Neurogastroenterology & Motility · doi:10.1111/nmo.13118 · Cited by 100
Self-citationRole of Corticotropin-releasing Factor in Gastrointestinal Permeability
Rodiño-Janeiro, B. K., Alonso-Cotoner, C., Pigrau, M., Lobo, B., Vicario, M., & Santos, J. (2015) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm14084 · Cited by 118
Baxter, M. F. A., Merino-Guzmán, R., Latorre, J. D., Mahaffey, B. D., Yang, Y., Teague, K. D., Graham, L. E., Wolfenden, A. D., Hernández-Velasco, X., Bielke, L. R., et al. (2017) · Frontiers in Veterinary Science · doi:10.3389/fvets.2017.00056 · Cited by 123
CRF and urocortin peptides as modulators of energy balance and feeding behavior during stress
Stengel, A., & Taché, Y. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00052 · Cited by 118
“The past decade witnessed an increasing knowledge on the peripheral expression and regulation of CRF and urocortin signaling systems and recognition of their implication in health and disease (Yuan et al., 2010; Buckinx et al., 2011; Overman et al., 2012; Diaz and Smani, 2013; Onorati et al., 2013).”
BackgroundNeurons and Glia in the Enteric Nervous System and Epithelial Barrier Function
Vergnolle, N., & Cirillo, C. (2018) · Physiology · doi:10.1152/physiol.00009.2018 · Cited by 106
Recognizing the role of the vagus nerve in depression from microbiota-gut brain axis
Tan, C., Yan, Q., Ma, Y., Fang, J., & Yang, Y. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.1015175 · Cited by 130
Kvidera, S. K., Horst, E. A., Sanz-Fernandez, M. V., Abuajamieh, M., Ganesan, S., Gorden, P. J., Green, H. B., Schoenberg, K. M., Trout, W. E., Keating, A. F., et al. (2017) · Journal of Dairy Science · doi:10.3168/jds.2017-13229 · Cited by 126
Pohl, C. S., Medland, J. E., & Moeser, A. J. (2015) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00206.2015 · Cited by 94
Self-citationBiology of heat stress; the nexus between intestinal hyperpermeability and swine reproduction
Mayorga, E. J., Ross, J. W., Keating, A. F., Rhoads, R. P., & Baumgard, L. H. (2020) · Theriogenology · doi:10.1016/j.theriogenology.2020.05.023 · Cited by 109
The Multifaceted Mast Cell in Inflammatory Bowel Disease
Hamilton, M. J., Frei, S. M., & Stevens, R. L. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000142 · Cited by 88
“that exposure of CRH to porcine ileum led to increased paracellular permeability.(124) Because degranulated MCs were found, var-”
BackgroundBonaz, B. L. (2022) · Neurogastroenterology & Motility · doi:10.1111/nmo.14456 · Cited by 94
Quigley, E. M. M. (2016) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x15621230 · Cited by 85
Mast cells in gastrointestinal disorders
Bischoff, S. C. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.02.018 · Cited by 92
“Psychological stress, which induces mast cell activation via corticotropin-releasing factor and increased gut permeability, has been implicated in the pathophysiology of IBS (and IBD) (Overman et al., 2012).”
BackgroundResultJones, H., Hargrove, L., Kennedy, L., Meng, F., Graf‐Eaton, A., Owens, J., Alpini, G., Johnson, C., Bernuzzi, F., Demieville, J., et al. (2016) · Hepatology · doi:10.1002/hep.28704 · Cited by 83
“5 Cromolyn sodium has also been used to treat the autoimmune disorder, irritable bowel disease(10, 11).”
Pigrau, M., Rodiño‐Janeiro, B. K., Casado‐Bedmar, M., Lobo, B., Vicario, M., Santos, J., & Alonso‐Cotoner, C. (2016) · Neurogastroenterology & Motility · doi:10.1111/nmo.12717 · Cited by 79
Burhans, W. S., Rossiter-Burhans, C. A., & Baumgard, L. H. (2022) · Journal of Dairy Science · doi:10.3168/jds.2021-21080 · Cited by 95
Psychosocial Stress and Immunity—What Can We Learn From Pig Studies?
Gimsa, U., Tuchscherer, M., & Kanitz, E. (2018) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2018.00064 · Cited by 93
“It has been shown that the release of mast cell proteases induced by corticotropin-releasing hormone (CRH) is regulated by the enteric nervous system (Overman et al., 2012).”
BackgroundMicrobiome and Mental Health, Specifically as It Relates to Adolescents
Simkin, D. R. (2019) · Current Psychiatry Reports · doi:10.1007/s11920-019-1075-3 · Cited by 85
Müller, B., Rasmusson, A. J., Just, D., Jayarathna, S., Moazzami, A. A., Novičić, Z. K., & Cunningham, J. L. (2021) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000965 · Cited by 84
“Another proposed mechanism via CRH is mast cell activation and the release of proteases (14).”
BackgroundDirect and indirect effects of pathogenic bacteria on the integrity of intestinal barrier
Shu, L.-Z., Ding, Y.-D., Xue, Q.-M., Cai, W., & Deng, H. (2023) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848231176427 · Cited by 89
Hu, C., Xiao, K., Song, J., & Luan, Z. S. (2013) · Animal Feed Science and Technology · doi:10.1016/j.anifeedsci.2013.02.003 · Cited by 78
Prado-Rebolledo, O. F., Delgado-Machuca, J. D. J., de Macedo, R. R. B., García-Márquez, L. J., Morales-Barrera, J. E., Latorre, J. D., Hernández-Velasco, X., & Téllez‐Isaías, G. (2016) · Avian Pathology · doi:10.1080/03079457.2016.1222808 · Cited by 80
“Activation of NFκB results in the expression of several inflammatory cytokines (Overman et al., 2012).”
BackgroundChen, Y., Wen, J., Deng, Z., Pan, X., Xie, X., & Peng, C. Y. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2020.104113 · Cited by 80
The Influence of Early Life Experience on Visceral Pain
Fuentes, I. M., & Christianson, J. A. (2018) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2018.00002 · Cited by 71
“Increased transepithelial resistance and mucosal-to-serosal flux was observed in porcine ileus explants following exposure to increasing amounts of CRF, which was blocked by a non-selective CRF1/2 antagonist or a mast cell stabilizer (Overman et al., 2012).”
BackgroundCurrent Landscape of Heart Failure Gene Therapy
Kieserman, J. M., Myers, V. D., Dubey, P. K., Cheung, J. Y., & Feldman, A. M. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.012239 · Cited by 68
Chronic Stress, Inflammation, and Colon Cancer: A CRH System-Driven Molecular Crosstalk
Baritaki, S., de Bree, E., Chatzaki, Ε., & Pothoulakis, C. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8101669 · Cited by 77
Immunoregulatory effect of mast cells influenced by microbes in neurodegenerative diseases
Girolamo, F., Coppola, C., & Ribatti, D. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.06.017 · Cited by 63
Yue, Y., Guo, Y., & Yang, Y. (2017) · Amino Acids · doi:10.1007/s00726-017-2424-3 · Cited by 65
“…profile of cytokines in jejunal tissues might act on the intestinal epithelium tight junctions, and lead to increased permeability of the intestinal mucosa to pathogenic bacteria and contribute to the higher incidence of intestinal infections (Al-Sadi et al. 2012, 2013; Overman et al. 2012).”
Role of enteric neurotransmission in host defense and protection of the gastrointestinal tract
Sharkey, K. A., & Savidge, T. C. (2014) · Autonomic Neuroscience · doi:10.1016/j.autneu.2013.12.006 · Cited by 58
“N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript extended by Overman et al. who showed that CRF acted via mast cells and through a TTXsensitive, likely cholinergic, neural pathway (Overman et al., 2012).”
BackgroundGonzález-Moret, R., Cebolla, A., Cortés, X., Baños, R. M., Navarrete, J., de la Rubia, J. E., Lisón, J. F., & Soria, J. M. (2020) · Scientific Reports · doi:10.1038/s41598-020-63168-4 · Cited by 58
Corticotropin-releasing factor receptor type 1 and type 2 interaction in irritable bowel syndrome
Nozu, T., & Okumura, T. (2015) · Journal of Gastroenterology · doi:10.1007/s00535-015-1086-8 · Cited by 61
Altered colonic sensory and barrier functions by CRF: roles of TLR4 and IL-1
Nozu, T., Miyagishi, S., Nozu, R., Takakusaki, K., & Okumura, T. (2018) · Journal of Endocrinology · doi:10.1530/joe-18-0441 · Cited by 59
Medland, J. E., Pohl, C. S., Edwards, L. L., Frandsen, S., Bagley, K., Li, Y., & Moeser, A. J. (2016) · Neurogastroenterology & Motility · doi:10.1111/nmo.12828 · Cited by 53
Self-citationUranga, J. A., Martínez, V., & Abalo, R. (2020) · Molecules · doi:10.3390/molecules25184314 · Cited by 53
“On the contrary, GI effects of stress are reduced by administration of selective CRF receptor antagonists, mast cell stabilizers and protease inhibitors [60,63,64].”
BackgroundAyyadurai, S., Gibson, A. J., D'Costa, S., Overman, E. L., Sommerville, L. J., Poopal, A. C., Mackey, E., Li, Y., & Moeser, A. J. (2017) · Journal of Leukocyte Biology · doi:10.1189/jlb.2hi0317-088rr · Cited by 52
“Although a link between the CRF system, MC activation, and intestinal permeability has been shown in animal models and in humans [10, 38, 39], the precise mechanisms have remained controversial.”
BackgroundMethodSelf-citationHussain, Z., & Park, H. (2022) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm22100 · Cited by 64
Lafuse, W. P., Gearinger, R., Fisher, S., Nealer, C., Mackos, A. R., & Bailey, M. T. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601269 · Cited by 52
Effect of Dietary Fiber and Metabolites on Mast Cell Activation and Mast Cell-Associated Diseases
Folkerts, J., Stadhouders, R., Redegeld, F. A., Tam, S., Hendriks, R. W., Galli, S. J., & Maurer, M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01067 · Cited by 61
Chatoo, M., Li, Y., Ma, Z., Coote, J., Du, J., & Chen, X. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00021 · Cited by 50
“Investigators have shown the participation of TNF-α, a mucosal mast cell mediator, in tight junction dysregulation, and altered intestinal permeability (13, 64).”
BackgroundShaito, A. A., Hasan, H. A., Habashy, K. J., Fakih, W., Abdelhady, S., Ahmad, F., Zibara, K., Eid, A. H., EL‐Yazbi, A. F., & Kobeissy, F. H. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102829 · Cited by 51
Present and Future Therapeutic Approaches to Barrier Dysfunction
Fortea, M., Albert-Bayo, M., Abril-Gil, M., Mall, J. G., Serra-Ruiz, X., Henao-Paez, A., Expósito, E., González-Castro, A. M., Guagnozzi, D., Lobo, B., et al. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.718093 · Cited by 57
Psychosocial stress-induced intestinal permeability in healthy humans: What is the evidence?
Torre, D. L., Oudenhove, L. V., Vanuytsel, T., & Verbeke, K. (2023) · Neurobiology of Stress · doi:10.1016/j.ynstr.2023.100579 · Cited by 64
“…studies using an Ussing chamber model with a porcine ileum demonstrated that CRH disturbed intestinal epithelial barrier function which involved mast cell dependent TNF-α and protease release and disruption of TJs (Moeser et al., 2007; Keita et al., 2010; Overman et al., 2012; Smith et al., 2010).”
Peters, S. A., Edogawa, S., Sundt, W. J., Dyer, R. B., Dalenberg, D. A., Mazzone, A., Singh, R. J., Moses, N., Smyrk, T. C., Weber, C., et al. (2017) · American Journal of Gastroenterology · doi:10.1038/ajg.2017.48 · Cited by 48
Horst, E. A., Mayorga, E. J., Al‐Qaisi, M., Rodríguez-Jiménez, S., Goetz, B. M., Abeyta, M. A., Gorden, P. J., Kvidera, S. K., & Baumgard, L. H. (2020) · Journal of Dairy Science · doi:10.3168/jds.2020-18860 · Cited by 48
“Consequences of CRF are mediated by stimulation of intestinal mast cell degranulation and release of pre-formed and de novo mediators, such as histamine, proteases, and cytokines, which negatively affect intestinal barrier function (Abraham and St. John, 2010; Overman et al., 2012).”
BackgroundSubacute stress and chronic stress interact to decrease intestinal barrier function in rats
Lauffer, A., Vanuytsel, T., Vanormelingen, C., Vanheel, H., Salim Rasoel, S., Tóth, J., Tack, J., Fornari, F., & Farré, R. (2016) · Stress · doi:10.3109/10253890.2016.1154527 · Cited by 48
“Mast cells have been suggested to play a central role in stress-induced hyper-permeability and visceral hypersensitivity through CRF-induced release of mediators like proteases and tumor necrosis factor a (TNFa) (Overman et al., 2012; Vanuytsel et al., 2014b; Vicario et al., 2010, 2012).”
BackgroundAnimal Models for Functional Gastrointestinal Disorders
Accarie, A., & Vanuytsel, T. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.509681 · Cited by 56
“Ex-vivo experiments demonstrated that CRH increased permeability via a TNF-α dependent mechanism (280).”
BackgroundBoyer, P. E., D'Costa, S., Edwards, L. L., Milloway, M., Susick, E., Borst, L. B., Thakur, S., Campbell, J. M., Crenshaw, J. D., Polo, J., et al. (2015) · British Journal of Nutrition · doi:10.1017/s000711451400422x · Cited by 47
“TNF is best recognised as a pro-inflammatory cytokine that is central to the pathogenesis of a number of inflammatory disorders, and to stress-induced intestinal permeability((39,40)).”
BackgroundSelf-citationThe Link Between Stress and Endometriosis: from Animal Models to the Clinical Scenario
Appleyard, C. B., Flores, I., & Torres-Reverón, A. (2020) · Reproductive Sciences · doi:10.1007/s43032-020-00205-7 · Cited by 55
Effect of two different short peripheral catheter materials on phlebitis development.
Karadağ, A., & Görgülü, S. (2000) · PubMed · Cited by 55
Kerschaver, C. V., Turpin, D. L., Michiels, J., & Pluske, J. R. (2023) · Animals · doi:10.3390/ani13101644 · Cited by 66
“The secretion of CRH from the hypothalamus and activation of intestinal CRH receptors cause hyperplasia and degranulation of mast cells in the intestinal mucosa [57,59,60].”
BackgroundThe overlap between IBS and IBD – what is it and what does it mean?
Stanisic, V., & Quigley, E. M. (2014) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2014.876361 · Cited by 41
Li, X., Zhao, J., Kasinath, V., Uehara, M., Jiang, L., Banouni, N., McGrath, M. M., Ichimura, T., Fiorina, P., Lemos, D. R., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci136618 · Cited by 45
Zhao, H., Yue, Y., Han, H., Chen, X., Lu, Y., Zheng, J., Hou, H., Lang, X.-M., He, L., Hu, Q., et al. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i6.999 · Cited by 39
Nozu, T., Miyagishi, S., Nozu, R., Takakusaki, K., & Okumura, T. (2017) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13787 · Cited by 39
Inflammation and Overlap of Irritable Bowel Syndrome and Functional Dyspepsia
Wang, C., & Fang, X. (2021) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm20175 · Cited by 45
Yu, W.-R., Jhang, J.-F., Jiang, Y.-H., & Kuo, H.-C. (2024) · Biomedicines · doi:10.3390/biomedicines12092051 · Cited by 39
“Furthermore, increases in sensory receptor expression, nerve hyperplasia, systemic inflammatory reactions, and stress may also contribute to IC/BPS [33].”
BackgroundCavin, J., Cuddihey, H., MacNaughton, W. K., & Sharkey, K. A. (2019) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00186.2019 · Cited by 45
Zhu, H., Pi, D., Leng, W., Wang, X., Hu, C. A., Hou, Y., Xiong, J., Wang, C., Qin, Q., & Liu, Y. (2017) · Innate Immunity · doi:10.1177/1753425917721631 · Cited by 42
“prostaglandins, cytokines, tryptase and histamine, which influence intestinal barrier function.(7) Nutrients such as amino acids and fatty acids have been proposed as regulators to restore the intestinal barrier.”
BackgroundInfluentialMaguey-González, J. A., Michel, M. A., Baxter, M. F. A., Tellez, G., Moore, P. A., Jr., Solís-Cruz, B., Hernández‐Patlan, D., Merino-Guzmán, R., Hernández-Velasco, X., Latorre, J. D., et al. (2018) · Animal Science Journal · doi:10.1111/asj.13011 · Cited by 38
Endogenous CRF in rat large intestine mediates motor and secretory responses to stress
Liu, S., Chang, J., Long, N., Beckwith, K., Talhouarne, G., Brooks, J., Qu, M., Ren, W., Wood, J. D., Cooper, S., et al. (2015) · Neurogastroenterology & Motility · doi:10.1111/nmo.12725 · Cited by 39
Zhan, C., Chen, D., Luo, J., Shi, Y., & Zhang, Y. (2018) · Molecular Medicine · doi:10.1186/s10020-018-0053-2 · Cited by 37
“Interestingly, a previous study suggested that intestinal epithelial barrier dysfunction is triggered by a mechanism that involves mast cell dependent TNF-α and protease release and disruption of paracellular tight junctions, owing to findings of increased TNF-α in intestinal epithelial barrier function (Overman et al…”
BackgroundHernández-Ramírez, J. O., Nava-Ramírez, M. D. J., Merino-Guzmán, R., Téllez‐Isaías, G., Vázquez‐Durán, A., & Méndez‐Albores, A. (2019) · Mycotoxin Research · doi:10.1007/s12550-019-00367-7 · Cited by 39
Opioid Use, Gut Dysbiosis, Inflammation, and the Nervous System
Jalodia, R., Abu, Y. F., Oppenheimer, M. R., Truitt, B., Meng, J., Chupikova, I., Tao, J., Ghosh, N., Dutta, R. K., Kolli, U., et al. (2022) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-021-10046-z · Cited by 43
Xu, X., Liu, L., & Yao, S. (2016) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1500181 · Cited by 37
“MCs are always adjacent to small-diameter unmyelinated nerve fibers that are primarily peptidergic fibers containing neuropeptides such as SP and CGRP, and can respond to noxious stimuli and induce pain (Park et al., 2003; Barbara et al., 2004).”
BackgroundInfluentialRivier, J., & RIVIER, C. L. (2013) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2013.10.006 · Cited by 38
“[PubMed: 7309372] Overman E, Rivier J, Moeser A. CRF induces intestinal epithelila barrier injury via the release of mast cell proteases and TNF-alpha.”
BackgroundInfluentialSelf-citationWang, M. Y., Li, Y., Gao, M., Song, L. W., Xu, M., Zhao, X., Jia, Y., Zhao, M., Sun, Y., & Hu, H. (2021) · Journal of Dairy Science · doi:10.3168/jds.2020-18738 · Cited by 37
Nozu, T., Takakusaki, K., & Okumura, T. (2014) · Endocrinology · doi:10.1210/en.2014-1421 · Cited by 37
Mall, J. G., Casado‐Bedmar, M., Winberg, M. E., Brummer, R. J., Schoultz, I., & Keita, Å. V. (2017) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izx002 · Cited by 37
l-Glutamine Represses the Unfolded Protein Response in the Small Intestine of Weanling Piglets
He, Y., Fan, X., Liu, N., Song, Q., Kou, J., Shi, Y., Luo, X., Dai, Z., Yang, Y., Wu, Z., et al. (2019) · Journal of Nutrition · doi:10.1093/jn/nxz155 · Cited by 34
An update on equine post‐operative ileus: Definitions, pathophysiology and management
Lisowski, Z. M., Pirie, R. S., Blikslager, A. T., Lefebvre, D., Hume, D. A., & Hudson, N. P. H. (2017) · Equine Veterinary Journal · doi:10.1111/evj.12801 · Cited by 64
“Neuropeptides (substance P or calcitonin gene-related peptide) released from afferent nerves have been hypothesised as playing a role [62; 63].”
BackgroundNozu, T., & Okumura, T. (2022) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm21002 · Cited by 35
Horn, N. L., Ruch, F. E., Miller, G., Ajuwon, K. M., & Adeola, O. (2014) · Journal of Animal Science · doi:10.2527/jas.2014-7673 · Cited by 38
“Several studies show a link between nursery pig stress and feed consumption that is related to gastrointestinal function, and furthermore, previous studies suggest a link between water consumption and feed intake in weaned pigs (Pluske et al., 1997; Patience, 2012).”
ResultHernández‐Patlan, D., Solís-Cruz, B., Adhikari, B., Pontin, K. P., Latorre, J. D., Baxter, M. F. A., Hernández-Velasco, X., Merino-Guzmán, R., Méndez‐Albores, A., Kwon, Y. M., et al. (2018) · Research in Veterinary Science · doi:10.1016/j.rvsc.2018.12.004 · Cited by 30
Guilarte, M., Vicario, M., Martínez, C., de Torres, I. M., Lobo, B., Pigrau, M., González-Castro, A. M., Rodiño‐Janeiro, B. K., Salvo‐Romero, E., Fortea, M., et al. (2020) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000789 · Cited by 35
Million, M., Zhao, J.-F., Luckey, A. E., Czimmer, J., Maynard, G. D., Kehne, J. H., Hoffman, D. C., & Taché, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073749 · Cited by 33
Metadata
- Authors
- Overman, E. L., Rivier, J. E., & Moeser, A. J.
- Affiliations
- North Carolina State University (US)
- Salk Institute for Biological Studies (US)
- Corresponding author
- Moeser, Adam J.
- ORCID
- Moeser, Adam J.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-06-29
- Volume
- 7
- Issue
- 6
- Pages
- e39935
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3386952
- OpenAlex
- W2125432409
- Cited by
- 207
- References
- 52
- Citations by year
- 2026: 8 · 2025: 9 · 2024: 10 · 2023: 18 · 2022: 17 · 2021: 13 · 2020: 19 · 2019: 17 · 2018: 17 · 2017: 26 · 2016: 12 · 2015: 14 · 2014: 15 · 2013: 8 · 2012: 3
- FWCI
- 12.42
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institutes of Health (DK-34987)
- U.S. Public Health Service (DKPO1026741)
- National Institute of Diabetes and Digestive and Kidney Diseases (K08DK084313, P30‐DK34987, P30DK034987)
- Center for Gastrointestinal Biology and Disease, School of Medicine, University of North Carolina at Chapel Hill (P30 DK34987, DK34987)
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Immunology and Microbiology › Immunology › Mast cells and histamine
- Keywords
- corticotropin-releasing factor, psychological stress, intestinal epithelial barrier, intestinal permeability, mast cell degranulation, mast cell proteases, TNF-α, enteric nervous system, tetrodotoxin, irritable bowel syndrome, inflammatory bowel disease, porcine ileum, transepithelial electrical resistance
- MeSH terms
- Animals, Corticotropin-Releasing Hormone, Dextrans, Ileum, Intestinal Mucosa, Mast Cells, Molecular Weight, Neutralization Tests, Peptide Fragments, Peptide Hydrolases, Permeability, Protease Inhibitors, Tumor Necrosis Factor-alpha, Cell Degranulation, Fluorescein-5-isothiocyanate, Enteric Nervous System, Protein Transport, Sus scrofa, Rats, Occludin, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.